CRIS Current Research Information System

AGOSTINELLI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.356
EU - Europa 7.164
AS - Asia 3.282
AF - Africa 481
SA - Sud America 30
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.323
GB - Regno Unito 2.177
CN - Cina 1.216
IT - Italia 1.068
DE - Germania 1.051
SE - Svezia 981
VN - Vietnam 693
SG - Singapore 670
IN - India 514
UA - Ucraina 396
IE - Irlanda 319
RU - Federazione Russa 291
FR - Francia 272
ZA - Sudafrica 191
EE - Estonia 153
CH - Svizzera 146
TG - Togo 126
CI - Costa d'Avorio 82
BG - Bulgaria 73
FI - Finlandia 65
JO - Giordania 56
NG - Nigeria 47
BE - Belgio 35
IR - Iran 31
CA - Canada 30
HR - Croazia 27
SC - Seychelles 24
LB - Libano 23
AT - Austria 22
BR - Brasile 19
GR - Grecia 18
JP - Giappone 17
NL - Olanda 14
HK - Hong Kong 10
KR - Corea 10
TR - Turchia 10
PL - Polonia 9
UZ - Uzbekistan 9
CL - Cile 8
CZ - Repubblica Ceca 8
AU - Australia 6
SK - Slovacchia (Repubblica Slovacca) 6
LU - Lussemburgo 5
PH - Filippine 5
PT - Portogallo 5
HU - Ungheria 4
IL - Israele 4
RO - Romania 4
AL - Albania 2
AM - Armenia 2
BD - Bangladesh 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
MU - Mauritius 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PK - Pakistan 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CR - Costa Rica 1
ES - Italia 1
GE - Georgia 1
GH - Ghana 1
ID - Indonesia 1
KW - Kuwait 1
LK - Sri Lanka 1
MK - Macedonia 1
MT - Malta 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 21.324
Salva come PNG Salva come JPEG
Città #
Southend 2.001
Fairfield 1.436
Chandler 893
Ashburn 802
Woodbridge 713
Houston 691
Wilmington 663
Seattle 603
Singapore 561
Princeton 544
Cambridge 501
Ann Arbor 453
Dong Ket 401
Dublin 319
Bologna 240
Nanjing 222
Westminster 211
Jacksonville 195
Padova 182
Bremen 137
Berlin 132
Bern 126
Lomé 126
Santa Clara 117
Saint Petersburg 114
Jinan 111
Beijing 104
New York 103
Shenyang 93
Redmond 86
Nanchang 84
Abidjan 82
Hebei 75
San Diego 73
Sofia 73
Changsha 70
Mülheim 64
Milan 62
Hyderabad 61
Medford 59
Amman 56
Helsinki 55
Jiaxing 55
Falls Church 51
Tianjin 51
Boardman 47
Abeokuta 46
Haikou 40
Redwood City 40
Zhengzhou 38
Hangzhou 37
Turin 36
Brussels 35
Dearborn 35
Norwalk 33
San Venanzo 33
Los Angeles 31
Des Moines 30
Taizhou 30
Olalla 29
Guangzhou 26
Ningbo 26
Mahé 22
Taiyuan 21
Toronto 21
London 20
Fremont 19
Bühl 18
Rome 18
Vienna 18
Verona 15
Florence 14
Lanzhou 14
Frankfurt am Main 13
Kunming 13
Kuban 12
Pune 12
Fuzhou 11
Leawood 11
Frankfurt Am Main 10
San Francisco 10
Tokyo 10
Ardabil 9
Lappeenranta 9
Phoenix 9
Ravenna 9
Lausanne 8
Monmouth Junction 8
Paris 8
Salsomaggiore Terme 8
São Paulo 8
Zanjan 8
Andover 7
Hefei 7
Istanbul 7
Naples 7
San Jose 7
Brescia 6
Catanzaro 6
Chiswick 6
Totale 14.882
Salva come PNG Salva come JPEG
Nome #
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 209
Biology and treatment of follicular lymphoma. 199
ANALYSIS OF THE CODING GENOME OF SPLENIC MARGINAL ZONE LYMPHOMA REVEALS MUTATIONAL ACTIVATION OF NOTCH2 AND OTHER PATHWAYS REGULATING MARGINAL ZONE DIFFERENTIATION 188
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 180
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 178
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 175
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma – Authors' reply 169
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 161
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 152
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 148
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. 145
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 144
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 143
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). 140
Expression of CD52 in peripheral T-cell lymphoma. 140
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 140
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. 139
Anaplastic Large Cell Lymphoma: a critical reappraisal 137
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 137
CD30 expression in peripheral T-cell lymphomas 136
IFI16 expression is related to selected transcription factors during B-cell differentiation 136
RALE051: a novel established cell line of sporadic Burkitt lymphoma 136
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 136
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 135
A case of primary MALT lymphoma of the endometrium presenting as an asymptomatic polyp. 135
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 134
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature. 132
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 130
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 129
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 129
BCL10 down-regulation in peripheral T-cell lymphomas. 129
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 128
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 127
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 127
Gastric MALT Lymphoma in a Sleeve Gastrectomy Specimen: Case Report and Literature Review 126
Histopathology of B-cell chronic lymphocytic leukemia. 123
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 123
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 122
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 122
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 122
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? 122
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 122
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 122
Pathobiology of hodgkin lymphoma. 122
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 120
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 120
MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN LYMPHOMAS WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK: INTER-LABORATORY REPRODUCIBILITY ON BORDERLINE SAMPLES 119
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 118
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 118
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. 117
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis 117
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups 116
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 116
Photodynamic therapy: An option in mycosis fungoides 115
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature 115
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 115
Prognostic markers in peripheral T-cell lymphoma. 114
Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report. 114
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 114
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion. 113
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 113
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 112
Pathobiology of anaplastic large cell lymphoma. 111
Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder 110
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. 110
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients. 109
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 109
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. 108
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 107
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 106
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 104
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 104
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 104
Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature 104
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 104
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. 103
Alopecia areata-like mycosis fungoides: Lions for lambs 103
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 103
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters 103
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report 103
Comparative proteomic profiling of Hodgkin lymphoma cell lines 102
Pathobiology of ALK-negative anaplastic large cell lymphoma. 101
Single-Agent Lenalidomide Is Effective in the Treatment of a Heavily Pretreated and Refractory Angioimmunoblastic T-Cell Lymphoma Patient. 101
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 101
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 101
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 101
Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. 100
Follicular lymphoma: still six characters in search of an author? 100
Construction and validation of a bone marrow tissue microarray. 99
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 99
Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified. 99
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 99
Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long term follow up and literature review 99
Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. 97
Identification of Novel Cryptic Chromosomal Abnormalities in Primary Myelofibrosis by Single-Nucleotide Polymorphism Oligonucleotide Microarray. 97
CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma 97
Bone marrow in Hodgkin lymphoma and mimickers. 96
Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm. 95
Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study 95
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes 95
Totale 12.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.910
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.910
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.877 0 0 63 391 578 564 695 750 766 393 272 405
2020/20213.175 635 239 191 112 63 146 61 146 371 146 155 910
2021/20224.088 314 151 240 284 436 242 80 282 202 350 886 621
2022/20234.404 538 599 250 596 334 332 132 242 707 104 317 253
2023/20241.238 64 228 116 104 109 227 89 82 43 87 36 53
2024/20251.191 232 870 89 0 0 0 0 0 0 0 0 0
Totale 21.975